Taking Creatine but Not Seeing Gains? Your Genes May Explain Why.

Vitamin D doesn’t just regulate calcium. It acts as a transcription factor, controlling gene expression in hundreds of tissues, including your muscles. One of the genes VDR regulates is SLC6A8, the creatine transporter. When your VDR is working well, it tells your muscle cells to make more creatine transporters, allowing them to absorb creatine efficiently. When VDR function is compromised, your muscles make fewer transporters, and creatine can’t get inside the cells where it needs to be.

The BsmI, FokI, and TaqI variants in VDR affect how sensitive your cells are to vitamin D signaling. Roughly 30-50% of people carry a VDR variant that reduces this sensitivity. You can have optimal vitamin D levels on paper (25-100 ng/mL) and still have functional vitamin D deficiency at the cellular level. Your muscles simply aren’t receiving the vitamin D signal to upregulate creatine transporters, which means supplemental creatine sits outside your muscle cells unable to enter.

This manifests as: taking creatine for months with no increase in muscle fullness or strength, despite perfect training adherence. Your muscles look flat. Your power output doesn’t improve. Your training partners on the same protocol see gains; you don’t. Standard bloodwork shows your vitamin D is fine, so your doctor tells you the supplement isn’t for you. What they’re missing is that your cells aren’t reading vitamin D signals correctly.

MTHFR is an enzyme that converts dietary folate into methylfolate, the active form your cells use for methylation reactions. Methylation is the process of adding methyl groups (CH3) to molecules, and it happens thousands of times per second in every cell. Creatine metabolism relies heavily on methylation. When you supplement with creatine, your body converts some of it into creatinine (a metabolic waste product), a process that requires methylation. If your methylation cycle is sluggish, creatinine accumulates, your kidneys have to work harder, and you don’t get the full ergogenic benefit of the creatine you’re taking.

The MTHFR C677T variant reduces this enzyme’s activity by roughly 40-70%. Approximately 40% of people of European ancestry carry at least one copy of the C677T variant. Even with a diet high in folate, your cells may be functionally folate-depleted because you cannot convert dietary folate into the active form your body needs. This creates a cascade of metabolic slowdown that affects methylation reactions throughout your body, including the creatine-to-creatinine conversion pathway.

You experience this as: fatigue during or after training despite good sleep and nutrition. Brain fog that worsens during intense training cycles. Slower recovery between sessions. Muscle soreness that lasts longer than expected. Because your methylation cycle is under-powered, your body cannot clear metabolic waste efficiently, and you feel the load of training more acutely than genetics-matched peers.

CYP1A2 is the enzyme responsible for metabolizing caffeine. It’s also involved in metabolizing several catecholamine-pathway compounds that affect alertness, focus, and sympathetic nervous system activation. If you’re a slow CYP1A2 metabolizer, caffeine stays in your bloodstream longer, and you’re more sensitive to its effects. If you’re a fast metabolizer, caffeine clears quickly, and standard doses may have minimal effect.

Roughly 50% of people are slow metabolizers of caffeine. Slow metabolizers who consume high-dose caffeine before training (the standard pre-workout protocol) experience jitteriness, elevated heart rate, and anxiety that outweighs any performance benefit. This defeats the purpose of pre-workout stimulants and creates a sympathetic overdrive that actually impairs power output and coordination. Your nervous system is too activated, your movements become erratic, and you fatigue faster despite feeling “wired.”

When you’re stacking creatine with caffeine-based pre-workouts (the standard recommendation), a CYP1A2 slow-metabolizer status becomes a limiting factor. You cannot tolerate the caffeine dose needed for performance benefit. You feel anxious, your sleep suffers, and your recovery is compromised by the lingering stimulant effect. Your training partners using the same protocol thrive; you feel worse than if you’d trained unfed.

COMT is the enzyme that breaks down dopamine and norepinephrine, two catecholamine neurotransmitters that power focus, motivation, and the sympathetic nervous system. The COMT Val158Met variant affects the enzyme’s activity. Met/Met carriers (slow metabolizers) break down catecholamines slowly, so these neurotransmitters stay in your synapse longer, amplifying their effects. Val/Val carriers (fast metabolizers) clear catecholamines quickly, so they experience less dopamine and norepinephrine signaling and need more external stimulation to feel the same effect.

Approximately 25-30% of people are Met/Met (slow metabolizers), and about 25-30% are Val/Val (fast metabolizers). Fast COMT metabolizers (Val/Val) are naturally less sensitive to caffeine, stimulants, and stress, but they also have lower baseline dopamine, which can impair motivation and focus during training. Slow COMT metabolizers (Met/Met) are highly sensitive to stimulation and become overstimulated easily, experiencing anxiety, elevated heart rate, and poor focus when given standard pre-workout doses.

When creatine is combined with caffeine and other ergogenic aids, COMT status determines your tolerance window. If you’re a fast metabolizer, you might need additional stimulation to feel energized for training. If you’re a slow metabolizer, standard pre-workout protocols leave you anxious and unable to focus. Either way, you’re not getting the best performance from your supplement stack because it’s not optimized for your catecholamine metabolism.

SOD2 (superoxide dismutase 2) is the master antioxidant enzyme in your mitochondria. During intense training, your muscles generate reactive oxygen species (ROS) as a byproduct of energy production. Moderate ROS exposure triggers beneficial adaptations: better mitochondrial function, improved insulin sensitivity, stronger muscle fibers. But excessive ROS without adequate antioxidant defense causes mitochondrial damage, accelerated muscle fatigue, and impaired recovery.

The SOD2 Ala16Val variant affects how efficiently your mitochondria produce SOD2. The Val/Val genotype is associated with lower SOD2 expression, meaning roughly 20-30% of people have reduced antioxidant capacity in their mitochondria. These individuals generate more oxidative stress during intense training and have less enzymatic defense to neutralize it. When you add creatine supplementation on top of intense training, you’re increasing metabolic demand and ATP turnover, which amplifies ROS production even further. Without adequate SOD2 to contain it, oxidative stress accumulates, your mitochondria become damaged, and your body signals exhaustion and fatigue.

You experience this as: excessive fatigue or soreness after creatine loading. Difficulty recovering between hard sessions even though you’re sleeping enough. Muscle soreness that worsens rather than improves with continued training. A sense that your body is breaking down faster than it’s adapting. Standard recovery protocols (sleep, protein, carbs) don’t fix it because the problem is mitochondrial oxidative damage, not insufficient calories or rest.

BCMO1 (beta-carotene monooxygenase 1) is the enzyme that converts dietary beta-carotene (the orange pigment in carrots, sweet potatoes, and leafy greens) into retinol, the active form of vitamin A. Retinol is essential for muscle protein synthesis. It regulates gene expression in muscle fibers, controls the retinoic acid signaling pathways that govern muscle growth, and supports the immune system’s recovery response after training stress.

The BCMO1 R267S and A379V variants reduce the enzyme’s efficiency. Approximately 45% of people carry at least one variant allele. These individuals convert plant-based beta-carotene into retinol at a rate 50-90% slower than people with normal BCMO1 function. This means your cells are retinol-depleted even if you eat plenty of orange vegetables. Your body cannot mount the full muscle-building response to training because the molecular signals for muscle protein synthesis are blunted.

Combine this with creatine supplementation, and the problem compounds. Creatine amplifies your training stimulus and increases the demand for muscle protein synthesis. If your vitamin A status is low due to poor BCMO1 function, your muscles cannot fully respond to that stimulus. You take creatine to amplify gains, but your biological capacity to actually build muscle is constrained by retinol deficiency. The result is plateau: your training intensity increases, creatine is present, but muscle growth lags.